Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Opioid receptor blocker which reduces desire for opioids and alcohol, use in psychiatry, neurology and addition medicine. More
Kappa opioid receptor agonist/ mü antagonist providing analgesia, while preventing respiratory depression More
Opioid receptor antagonist reducing opioid induced respiratory depression More
Treatment of movement disorders associated with organic central nervous system conditions, e.g. Huntington's chorea, hemiballismus and senile chorea. More
MRI contast medium More
Zolmitripan Oral Dispersible Film (ODF) is a a novel, non-mucoadhesive, fast dissolving oral dosage form of Zolmitriptan More
Related Reports
Market Research Reports provided by reports.iptechex.com
Oct 2010 - 112 pages - $7,600
Oct 2010 - 53 pages - $1,000
Jun 2006 - 1068 pages - $2,495
Apr 2008 - 250 pages - $3,995
Mar 2011 - 107 pages - $3,500
Feb 2012 - 64 pages - $1,085
Jan 2011 - 80 pages - $1,500
Sep 2011 - 39 pages - $250
Dec 2007 - 196 pages - $1,390
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us